Zantac / Ranitidine (NDMA Cancer) Lawsuit in Maryland

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Maryland has a 3-year statute of limitations for personal injury claims (Md. Code Ann., Cts. & Jud. Proc. § 5-101) with the discovery rule. Maryland applies contributory negligence in tort cases, but pharmaceutical strict product liability claims do not typically involve claimant fault as a complete bar. Maryland courts apply a version of the Frye-Reed standard for novel scientific evidence — similar to the general acceptance test used in Delaware — potentially more favorable than Daubert for Zantac causation experts.

3 years from date of cancer diagnosis discovery (Frye-Reed standard — potentially favorable)

Maryland Data

Exposure in Maryland

Source: U.S. Census Bureau 2024

Source: Maryland Cancer Registry 2024

Source: Maryland evidentiary law — Reed v. State

Medical Resources

Clinics & Specialists in Maryland

Johns Hopkins Kimmel Cancer Center

University of Maryland Greenebaum Comprehensive Cancer Center

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview